Market Overview

Form 4 From Aldeyra Therapeutics Shows Purchase Of 200K Shares By Perceptive's Joseph Edelman, A 10% Owner Of Aldeyra, At $7.25 On Sept. 19

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Insider Trades

 

Related Articles (ALDX)

Partner Center

Loading...